Current Medicinal Chemistry
Title:Meet the Editorial Board:
Volume: 22 Issue: 12
Author(s): Krzysztof W. Pankiewicz
Affiliation:
Export Options
About this article
Cite this article as:
Pankiewicz W. Krzysztof, Meet the Editorial Board:, Current Medicinal Chemistry 2015; 22 (12) . https://dx.doi.org/10.2174/092986732212150326105150
DOI https://dx.doi.org/10.2174/092986732212150326105150 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Macrophages in Rheumatoid Arthritis
Current Pharmaceutical Design The Type III Secretion System as a Source of Novel Antibacterial Drug Targets
Current Drug Targets A Systematic and Meta-Analysis Study on the Prevalence of Tuberculosis and Relative Risk Factors for Prisoners in Iran
Infectious Disorders - Drug Targets Advances in TB Vaccinology
Current Respiratory Medicine Reviews Nanoparticles and Immune Cells
Current Pharmaceutical Design Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis Agents
Current Clinical Pharmacology The Manzamines as an Example of the Unique Structural Classes Available for the Discovery and Optimization of Infectious Disease Controls Based on Marine Natural Products
Current Pharmaceutical Design In Silico (3D-QSAR) Designed, Study, Synthesis and Anti-tubercular Evaluation of Pyrazolo-Pyrimidine Derivatives
Anti-Infective Agents Expression, Purification and Characterisation of Haemophilus influenzae 3-Isopropylmalate Dehydrogenase (LeuB)
Protein & Peptide Letters Preface
Current Drug Targets Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
Current Medicinal Chemistry Targeting Intracellular Targets
Current Drug Delivery An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Dried Blood Spots: A New Tool for Tuberculosis Treatment Optimization
Current Pharmaceutical Design The α/β Hydrolase Fold Proteins of Mycobacterium tuberculosis, with Reference to their Contribution to Virulence
Current Protein & Peptide Science Recent Patents and New Strategies in the Treatment of Psoriasis
Recent Patents on Anti-Infective Drug Discovery DC-SIGN Antagonists, a Potential New Class of Anti-Infectives
Current Medicinal Chemistry Cannabinoids and Schizophrenia: Therapeutic Prospects
Current Pharmaceutical Design Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis
Current Pharmaceutical Design